ASCO | OriCell Therapeutics Announces Oral Presentation at 2022 ASCO Annual Meeting Detailing Results from Phase I POLARIS Study of OriCAR-017

/PRNewswire/ -- OriCell Therapeutics Co., Ltd (OriCell), a leading innovative biopharmaceutical company pioneering novel oncology cell therapies for the unmet...

Related Keywords

Mccormick Place ,Illinois ,United States ,Shanghai ,China ,Chicago , ,Oricar Technology Platform ,Prnewswire Oricell Therapeutics Co Ltd ,Refractory Multiple Myeloma ,Oral Abstract ,Hematologic Malignancies ,Plasma Cell ,Oricell Therapeutics ,Oricell Therapeutics Co ,Ltd ,Biotechnology ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Pharmaceuticals ,